+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Orthopaedic Digit Implants Market Growth Analysis - Market Size, Share, Forecast Trends and Outlook Report (2025-2034)

  • PDF Icon

    Report

  • 350 Pages
  • July 2025
  • Region: Global
  • Expert Market Research
  • ID: 6163265
The global orthopaedic digit implants market size reached around USD 6.37 Billion in 2024. The market is projected to grow at a CAGR of 7.70% between 2025 and 2034 to reach nearly USD 13.38 Billion by 2034.

Orthopaedic Digit Implants: Introduction

Devices that are used for the replacement of deformed and damaged bones, cartilage, or joints are known as orthopaedic digit implants. These implants are used to treat severe fractures that require realignment and fixation for adequate healing. They can also be used in cases when bone fails to regenerate, producing bone defects.

Global Orthopaedic Digit Implants Market Analysis

Major companies in the market are initiating strategic mergers and acquisition deals to achieve market growth and stability. For example, Conformis has recently agreed to be acquired by restor3d, a North Carolina startup that spun out of Duke University in 2017. Conformis is nearly two decades old and a major market player that manufactures 3D-printed and personalized orthopaedic implants. restor3d is alleged to dole out USD 2.27 in cash for each of Conformis' outstanding shares of common stock. Such deals are set to improve the market growth with their upcoming launches and developments influencing the global orthopaedic digit implants market growth.

Increasing technological advancements are also playing a significant role in the market growth and it is also backed by some observational studies. For example, a study published on PMC concluded that there are various advantages associated with the application of 3D printing metal implants in orthopaedic applications, such as personalization, promotion of osseointegration, short production cycle, and high material utilization. Additionally, the increasing knowledge of modeling software among surgeons is also a factor contributing to the advantages.

The key players in the market are focused on launching new and effective products to curb osteoarthritis discomfort in patients which is propelling the market growth. Such as the FDA approved the MISHA Knee System which is an implantable shock absorber effective in partially reducing load on the knee joint. This load reduction is expected to result in reduced pain and preserve the functionality of the knee. This device would be implanted subcutaneously during an outpatient-compatible procedure. Such approvals are directly contributing to market growth.

Global Orthopaedic Digit Implants Market Segmentation

The report titled “Orthopaedic Digit Implants Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:

Market Breakup by Product Type

  • Metatarsal Joint Implants
  • Metacarpal Joint Implants
  • Toe Intramedullary Digit Implants
  • Scaphoid Bone Digit Implants
  • Hemi phalangeal Digit Implants

Market Breakup by Material

  • Pyrocarbon
  • Titanium
  • Nitinol
  • Other Materials

Market Breakup by End User

  • Hospitals
  • Orthopaedic Clinics
  • Home Care
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Orthopaedic Digit Implants Market Overview

The increasing prevalence of arthritis and other problems associated with arthritis conditions, among the geriatric population, is a major factor driving the market growth. The rising geriatric population worldwide is a major factor influencing the market growth due to the increasing number of bone issues associated with the geriatric population. The increasing number of mishaps and accidents also contributes to the market growth.

The increasing technological developments are also expected to drive the market growth further. For example, the integration of robotic assistance, coupled with artificial intelligence and machine learning in the orthopaedic operating room is expected to further drive the orthopaedic digit implants market demand in the coming years.

North America is leading the regional market and is expected to keep leading in the coming years as well. The increased prevalence of osteoarthritis, coupled with the rising geriatric population, is a major factor driving the market growth. The presence of key market players and the continuous launches of new products are expected to further propel the regional market growth.

Global Orthopaedic Digit Implants Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Teijin Nakashima Medical Co., Ltd.
  • Johnson and Johnson Services, Inc.
  • Wright Medical Group N.V.
  • Integra Lifesciences
  • Stryker
  • Smith and Nephew
  • Zimmer Biomet Holdings, Inc.
  • VILEX IN TENNESSEE, INC.
  • Acumed LLC.
  • Merete Medical GmbH
  • Advin Healthcare

This product will be delivered within 3-5 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Orthopaedic Digit Implants Market Overview
3.1 Global Orthopaedic Digit Implants Market Historical Value (2018-2024)
3.2 Global Orthopaedic Digit Implants Market Forecast Value (2025-2034)
4 Global Orthopaedic Digit Implants Market Landscape
4.1 Global Orthopaedic Digit Implants Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Orthopaedic Digit Implants Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Material
5 Global Orthopaedic Digit Implants Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Orthopaedic Digit Implants Market Segmentation
6.1 Global Orthopaedic Digit Implants Market by Product Type
6.1.1 Market Overview
6.1.2 Metatarsal Joint Implants
6.1.3 Metacarpal Joint Implants
6.1.4 Toe Intramedullary Digit Implants
6.1.5 Scaphoid Bone Digit Implants
6.1.6 Hemi phalangeal Digit Implants
6.2 Global Orthopaedic Digit Implants Market by Material
6.2.1 Market Overview
6.2.2 Pyrocarbon
6.2.3 Titanium
6.2.4 Nitinol
6.2.5 Other Materials
6.3 Global Orthopaedic Digit Implants Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Orthopaedic Clinics
6.3.4 Home Care
6.3.5 Others
6.4 Global Orthopaedic Digit Implants Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Orthopaedic Digit Implants Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Orthopaedic Digit Implants Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Orthopaedic Digit Implants Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Orthopaedic Digit Implants Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Orthopaedic Digit Implants Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Teijin Nakashima Medical Co., Ltd.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Johnson and Johnson Services, Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Wright Medical Group N.V.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Integra Lifesciences
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Stryker
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Smith and Nephew
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Zimmer Biomet Holdings, Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 VILEX IN TENNESSEE, INC.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Acumed LLC.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Merete Medical GmbH
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Advin Healthcare
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
18 Global Orthopaedic Digit Implants Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Teijin Nakashima Medical Co., Ltd.
  • Johnson and Johnson Services, Inc.
  • Wright Medical Group N.V.
  • Integra Lifesciences
  • Financial Portfolio
  • Stryker
  • Smith and Nephew
  • Zimmer Biomet Holdings, Inc.
  • VILEX IN TENNESSEE, INC.
  • Acumed LLC.
  • Merete Medical GmbH
  • Advin Healthcare